Boards:
Quotes:
Favorites
Hot
Monitor
Movers
Level 2
NewsWire
Menu
Boards
Stocks
Commodities
Forex
Cryptocurrency
The Lounge
Advanced Search
News
iHub Newswire
All Company News
iHub Market News
News Scanner
Price & News Alerts
InvestorsHub Daily
Newsletters
Market Data
Monitor
Level 2
Live Charts
Trades
Portfolio
Economic Calendar
Follow Feed
Trader Alerts
Price Alerts
Markets
Crypto
Forex
Commodities
Futures
Discover
Market Movers
Options Flow
Breakouts
Broker Review
Breakout Boards
Most Read
Most Posted
Most Followed Members
Active Boards
New Boards
Site Stats
PostStream
My Stocks Activity
Ticker Buzz Cloud
Subscribe
Login/Register
Support
1-888-992-3836
help@advfn.com
S&P 500
5,544.59
-0.78%
US Tech 100
19,247.91
-0.12%
Dow Jones
40,665.02
-1.29%
Brent Oil
84.08
-0.48%
Bitcoin
63,797.38
-0.45%
Register for streaming realtime charts, analysis tools, and prices.
Get Started
Home
Investing
Stocks
USA
NASDAQ
AVEO Pharmaceuticals Inc
(AVEO)
AVEO Pharmaceuticals Inc (AVEO) News
News
News Scanner
Streaming News
Highlight Phrases
AVEO
AVEO Pharmaceuticals (AVEO)
AVEO Pharmaceuticals Inc (NASDAQ)
Avecho Biotechnology Limited (ASX)
Date:
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
2009
2008
2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
Regulatory News
Text Search:
Sort by:
newest to oldest
oldest to newest
Non-Regulatory News
Showing the most relevant articles for your search:
NASDAQ:AVEO
1
2
3
4
5
6
7
8
9
10
Next >>
Date
Time
Source
Headline
Symbol
Company
07/18/2024
1:00PM
iHub Newswire
Featured
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton
03/28/2024
3:22PM
GlobeNewswire Inc.
CORRECTION – AVEO Oncology Announces Appointment of Chief Medical Officer and Formation of Scientific Advisory Committee
NASDAQ:AVEO
AVEO Pharmaceuticals Inc
03/25/2024
8:10AM
GlobeNewswire Inc.
AVEO Oncology Announces Appointment of Chief Medical Officer and Formation of Scientific Advisory Committee
NASDAQ:AVEO
AVEO Pharmaceuticals Inc
02/06/2024
8:10AM
GlobeNewswire Inc.
AVEO Oncology Announces Publication of Long-Term Survival in Patients With Relapsed/Refractory Advanced Renal Cell Carcinoma Treated With Tivozanib: Analysis of the Phase III TIVO-3 Trial in The Oncologist
NASDAQ:AVEO
AVEO Pharmaceuticals Inc
01/16/2024
7:30AM
GlobeNewswire Inc.
AVEO Oncology Enrolls First Patient in Pivotal FIERCE-HN Clinical Trial to Evaluate Ficlatuzumab in Combination with ERBITUX® (cetuximab) in Patients with HPV-negative Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)
NASDAQ:AVEO
AVEO Pharmaceuticals Inc
01/30/2023
4:08PM
Edgar (US Regulatory)
Termination of Registration of a Class of Security Under Section 12(g) (15-12g)
NASDAQ:AVEO
AVEO Pharmaceuticals Inc
01/24/2023
6:07AM
Edgar (US Regulatory)
Notice of Effectiveness (effect)
NASDAQ:AVEO
AVEO Pharmaceuticals Inc
01/24/2023
6:07AM
Edgar (US Regulatory)
Notice of Effectiveness (effect)
NASDAQ:AVEO
AVEO Pharmaceuticals Inc
01/24/2023
6:07AM
Edgar (US Regulatory)
Notice of Effectiveness (effect)
NASDAQ:AVEO
AVEO Pharmaceuticals Inc
01/19/2023
5:20PM
Edgar (US Regulatory)
Statement of Changes in Beneficial Ownership (4)
NASDAQ:AVEO
AVEO Pharmaceuticals Inc
01/19/2023
5:17PM
Edgar (US Regulatory)
Statement of Changes in Beneficial Ownership (4)
NASDAQ:AVEO
AVEO Pharmaceuticals Inc
01/19/2023
5:17PM
Edgar (US Regulatory)
Statement of Changes in Beneficial Ownership (4)
NASDAQ:AVEO
AVEO Pharmaceuticals Inc
01/19/2023
5:16PM
Edgar (US Regulatory)
Statement of Changes in Beneficial Ownership (4)
NASDAQ:AVEO
AVEO Pharmaceuticals Inc
01/19/2023
5:16PM
Edgar (US Regulatory)
Statement of Changes in Beneficial Ownership (4)
NASDAQ:AVEO
AVEO Pharmaceuticals Inc
01/19/2023
5:05PM
Edgar (US Regulatory)
Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)
NASDAQ:AVEO
AVEO Pharmaceuticals Inc
01/19/2023
4:47PM
Edgar (US Regulatory)
Post-effective Amendment to Registration Statement (pos Am)
NASDAQ:AVEO
AVEO Pharmaceuticals Inc
01/19/2023
4:46PM
Edgar (US Regulatory)
Post-effective Amendment to Registration Statement (pos Am)
NASDAQ:AVEO
AVEO Pharmaceuticals Inc
01/19/2023
4:44PM
Edgar (US Regulatory)
Post-effective Amendment to an S-8 Filing (s-8 Pos)
NASDAQ:AVEO
AVEO Pharmaceuticals Inc
01/19/2023
4:43PM
Edgar (US Regulatory)
Post-effective Amendment to an S-8 Filing (s-8 Pos)
NASDAQ:AVEO
AVEO Pharmaceuticals Inc
01/19/2023
4:42PM
Edgar (US Regulatory)
Post-effective Amendment to an S-8 Filing (s-8 Pos)
NASDAQ:AVEO
AVEO Pharmaceuticals Inc
01/19/2023
4:40PM
Edgar (US Regulatory)
Post-effective Amendment to an S-8 Filing (s-8 Pos)
NASDAQ:AVEO
AVEO Pharmaceuticals Inc
01/19/2023
4:40PM
Edgar (US Regulatory)
Post-effective Amendment to an S-8 Filing (s-8 Pos)
NASDAQ:AVEO
AVEO Pharmaceuticals Inc
01/19/2023
4:38PM
Edgar (US Regulatory)
Post-effective Amendment to an S-8 Filing (s-8 Pos)
NASDAQ:AVEO
AVEO Pharmaceuticals Inc
01/19/2023
4:35PM
GlobeNewswire Inc.
LG Chem Completes Acquisition of AVEO Oncology
NASDAQ:AVEO
AVEO Pharmaceuticals Inc
01/18/2023
8:41AM
Edgar (US Regulatory)
Current Report Filing (8-k)
NASDAQ:AVEO
AVEO Pharmaceuticals Inc
01/05/2023
4:59PM
Edgar (US Regulatory)
Current Report Filing (8-k)
NASDAQ:AVEO
AVEO Pharmaceuticals Inc
12/23/2022
4:02PM
Edgar (US Regulatory)
Additional Proxy Soliciting Materials (definitive) (defa14a)
NASDAQ:AVEO
AVEO Pharmaceuticals Inc
12/22/2022
4:47PM
Edgar (US Regulatory)
Statement of Changes in Beneficial Ownership (4)
NASDAQ:AVEO
AVEO Pharmaceuticals Inc
12/02/2022
9:07AM
Edgar (US Regulatory)
Additional Proxy Soliciting Materials (definitive) (defa14a)
NASDAQ:AVEO
AVEO Pharmaceuticals Inc
12/02/2022
9:05AM
Edgar (US Regulatory)
Current Report Filing (8-k)
NASDAQ:AVEO
AVEO Pharmaceuticals Inc
Showing the most relevant articles for your search:
NASDAQ:AVEO
1
2
3
4
5
6
7
8
9
10
Next >>